Fenwick & West advised iRhythm Technologies, Inc. on the offering, and Davis Polk & Wardwell advised the initial purchasers. iRhythm Technologies, Inc. (Nasdaq: IRTC) announced its...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Tenaya Therapeutics on the transaction, and Davis Polk & Wardwell advised the underwriters. Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage...
You must be a Standard 1 Year member to access this content.
Weil, Gotshal & Manges advised Marvell Technology, Inc., and Davis Polk & Wardwell advised the representatives of the underwriters on the offering. Marvell Technology, Inc. (Nasdaq:MRVL)...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the initial purchasers in the offering and also advised the counterparties on capped call transactions. Bloom Energy Corporation (NYSE: BE)...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Texas Instruments on the offering, and Simpson Thacher advised the underwriters involved. Texas Instruments Incorporated announced the public offering of an aggregate of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics on the deal, while Davis Polk advised the representatives of the several underwriters. Denali Therapeutics, a biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agents in the transaction. The transaction consists in a new SEC-registered at-the-market offering program by Denali Therapeutics Inc. under which Denali...
You must be a Standard 1 Year member to access this content.
